Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

BACKGROUND: Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. METHODS: We developed a budget impact model to a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clinicoecon Outcomes Res
Autori principali: Abogunrin, Seye, Hortobagyi, Linda, Remak, Edit, Dinet, Jerome, Gabriel, Sylvie, Bakheit, Abdel Magid O
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386804/
https://ncbi.nlm.nih.gov/pubmed/25878510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S76141
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi